Mycopreneur

Kukuni is a Los Angeles based psychedelic recording and performing outfit helmed by Willy Christie.Kukuni's debut release is out now on Liquid Culture records - Willy joins us on the Mycopreneur podcast today to discuss the anatomy of making a psychedelic record, with special attention given to the songwriting process, technical equipment used, and how to streamline nascent inspiration into an actual public-facing album recorded in a professional studio. Please consider rating, reviewing, and sharing the podcast wherever you're listening. Hosted on Acast. See acast.com/privacy for more information.

Charles McBryde is a new media creator and consultant based in Los Angeles - he joins the Mycopreneur podcast today to share insights from his time on the ground in Ukraine in an active theater of war, as well as his impressions about the 'cult of spirituality and new age mysticism' that's developing around the use of psychedelics in the U.S.Please consider rating, reviewing, and sharing the episode wherever you're listening - Hosted on Acast. See acast.com/privacy for more information.

Patrick Moher is the President of Microdose, one of the leading psychedelic platforms and the team behind the Wonderland psychedelic conference.He joins Mycopreneur to talk about his rise to the current position he holds, the future of the psychedelic industry, and why there's no room for absolutism in the psychedelic space.Please consider rating, reviewing, and sharing this episode. Hosted on Acast. See acast.com/privacy for more information.

Willy Myco is an underground mushroom legend who has educated the world on all facets of cultivating mushrooms and running an underground mushroom business for decades. Today he joins us on the Mycoprneeur podcast to discuss the origins of his legacy, the genetics he's currently working with, the state of the mushroom community, and where we're headed from here as a movement. Please consider rating, reviewing, and sharing the podcast Hosted on Acast. See acast.com/privacy for more information.

Hernan Castro started cultivating Lion's Mane and other functional mushrooms after learning that they may be able to help his father cope with a serious medical diagnosis.In the years since then, he's leveraged his academic chemistry background to create a tincture and tea company called Desert Alchemist - Hernan discusses his approach to extraction, his tips for scaling your mycopreneurial venture, and the robust Funga of Arizona in this episode. Please consider rating, reviewing, and sharing the podcast Hosted on Acast. See acast.com/privacy for more information.

In this episode, we learn about the backstory of Third Wave founder Paul Austin - from the origins of his stalwart psychedelic brand Third Wave in a Budapest park on LSD, to the six year trajectory that has led him to become a published author and founding member of the Microdosing Collective - to the year ahead for Third Wave, and why the psychedelic conference circuit has not reached its full potential yet. Please consider rating, reviewing, and sharing this podcast Hosted on Acast. See acast.com/privacy for more information.

Paul Nolan is an international DJ, record producer, and mentor who is shaping the future of sound in psychedelic therapy.As the head of the forthcoming Microdose record label, Paul is helping to guide the roll out a number of different sonic expressions ranging from a better live audio system for immersive musical experiences to music for patients exploring psychedelic treatment options in clinics. He joins us to talk about his career, the dynamics of audio engineering, and the future of music in a legal and regulated psychedelic therapy landscape. Hosted on Acast. See acast.com/privacy for more information.

Raad Seraj is devoted to expanding access to pools of capital to a broader and more diverse set of Founders in the psychedelic space. He is the host of the Minority Trip Report Podcast, and is intimately involved in creating and executing deal flow between Founders and Funds in the emergent psychedelic medicine space. Today we discuss how Raad's upbringing in Bangladesh and Saudi Arabia has helped to shape the global lens and network that he's developed, and why funding more diverse Founders in the psychedelic space is a net positive for everyone involved. We also talk about the role of satire and art in today's psychedelic ecosystem, and what concrete steps he is taking to ensure that a broader set of solutions to societies most pressing challenges are fostered and supported through inception to tangible impact. Please consider rating and reviewing the podcast wherever you're listening. Hosted on Acast. See acast.com/privacy for more information.

Dr. Raj Mehra joins the podcast today to discuss the ongoing clinical trials that Seelos Therapeutics is conducting to investigate Racemic Ketamine as an effective drug candidate for treating patients with Acute Suicidal Ideation and Behavior -The suicide crises in the United States and beyond is an epidemic in itself, and Seelos Therapeutics is working towards delivering the worlds first FDA-approved ketamine treatment for individuals with ASIB. In this episode, Dr. Mehra discusses the clinical data suggesting that R-Ketamine is an effective treatment to help mitigate the suicide crises, as well as the Seelos Therapeutics patenting strategy and and path that a drug must take in order to be adapted into medicalized use. Please consider rating and reviewing the podcast wherever you're listening. Hosted on Acast. See acast.com/privacy for more information.

Haya Al-Hejailan joins us to discuss the future of psychedelics and psychedelic-assisted therapy in the South West Asian North African Region - a decolonize term for the 'Middle East".We discuss Haya's \discovery of altered states, her public-facing advocacy for psychedelics as a tool with a serious future in the SWANA region, misconceptions about life in Sadi Arabia, and much more.Please consider rating, reviewing, and sharing the podcast wherever you're listening. Hosted on Acast. See acast.com/privacy for more information.